Early mechanics
Suck or latch failure, low intake volumes, fatigue with feeding, early respiratory context, tube or specialist support, and the difference between acquisition and endurance.
PHENOTYPE · ORAL / GI / ENT
The better-characterized histories extend well beyond food selectivity. They include suck and latch, chewing, swallowing, dentition, oral mucosa, reflux, vomiting, motility, retention, fuel state, hearing, sinus and mastoid disease, airway, vitamin D, growth, and bone.
ORAL PHENOTYPE
Each layer has a different examination, competing explanation, and next test.
Suck or latch failure, low intake volumes, fatigue with feeding, early respiratory context, tube or specialist support, and the difference between acquisition and endurance.
Absent or inefficient chewing, prolonged dependence on mashed textures, pocketing, gagging, oral tone, coordination, and the mechanics needed to safely advance texture.
Clinical dysphagia, cough or choking, aspiration concern, laryngeal or airway context, and whether an instrumental swallow assessment was indicated or completed.
Late or painful eruption, retained primary teeth, dental surgery, bite or palate findings, tooth and nail morphology, and access to dental care.
Oral ulcers or bleeding, toothpaste or brushing reactions, temperature sensitivity, aversion, pain, and the distinction between barrier injury and sensory avoidance.
Oral-motor planning, speech production, AAC, fatigue, apraxia-like descriptions, and why spoken output cannot be used as a proxy for understanding.
MALE ORAL FUNCTION × VITAMIN D3
One deeply characterized male history includes no-chew or mashed-food dependence, very late and painful dentition, retained primary teeth requiring dental surgery, oral mucosal reactions, and a reported history of undetectable vitamin D3 or rickets in infancy. D3 injections and occupational therapy preceded a reported motor gain.
The time sequence is important. It does not prove that vitamin D caused the oral phenotype or the motor response.A separate male history reports vitamin-D absorption concern and developmental slowing after prolonged infant vomiting, while explicitly reporting no chewing or swallowing problem.
This within-sex contrast argues for measuring oral mechanics, GI absorption, nutrient status, mobility, and bone health as separate variables.GI & FUEL PHYSIOLOGY
Bowel and fuel observations recur across molecular groups, but the source set does not support one shared GI mechanism.
Reflux, recurrent vomiting, cyclic-vomiting descriptions, illness or constipation coupling, medication effects, and recovery.
Constipation, stool retention, painful bowel movements, toilet-learning context, distension, diarrhea, and bowel burden that may alter sleep or function.
Low intake, fasting intolerance, ketosis or hypoglycemia histories, dehydration, fatigue or shutdown-like states, and the timing of functional change around intake.
Serial weight and height, diet texture, vitamin D, calcium–phosphate–PTH context, iron and other clinically indicated nutrients, mobility, puberty, and bone health.
BEST NEXT DATA
Prospective stool form and frequency, retention and pain, intake and hydration, weight, fasting tolerance when clinically indicated, medication timing, and a repeated short measure of function before and after the state changes.
ENT, HEARING & AIRWAY
The current record includes both burden and controls: structural disease with reassuring audiology, snoring without obstructive sleep apnea, and mouth or nasal symptoms without recurrent otitis.
Recurrent otitis, middle-ear fluid, tympanometry, formal audiology, hearing aids or supports, and explicit records in which hearing remained reassuring.
Sinonasal disease, mastoid effusion, congestion, imaging findings, and the distinction between structural burden and infection history.
Adenoidal disease, tonsil burden, deviated septum, mouth-open breathing, operative history, and response to local treatment.
Snoring, witnessed pauses, congestion, sleep-disordered breathing, polysomnography, and cases in which snoring occurred without obstructive sleep apnea.
SAME LANE · DIFFERENT MEASUREMENTS
These selected deep-packet examples are evidence windows, not a prevalence numerator. Each retains life stage, evidence tier, measured finding, reassuring control, and missing primary record—without publishing a case code or exact molecular coordinate.
A brain MRI documented near-complete bilateral paranasal sinus mucosal disease and trace-to-mild left mastoid fluid. Formal audiology four days later showed Type-A tympanograms bilaterally, robust DPOAEs from 2–5 kHz, and soundfield responses of 20 dB to speech and 25 dB across 500–4,000 Hz in the better ear.
Compiled clinical material preserves right mastoid fluid, bilateral ethmoid and maxillary inflammatory change, and mild adenoidal hypertrophy; adenoidectomy followed the next year.
Across separate histories, middle-ear procedures, adenoid surgery, later mastoid or ENT burden, quiet interval examinations, and reassuring audiology appear in different combinations.
The chronology includes childhood tonsil and adenoid surgery, repeated tympanostomy-tube procedures for fluid, reported low-frequency hearing loss, and later tinnitus or intermittent unilateral muffling. A subsequent polysomnogram was reported as normal.
Source scope: selected de-identified longitudinal packets and linked clinical extracts reviewed through 23 July 2026. F = direct formal record; R = reported formal or clinical content; P = parent-observed chronology.
ORAL × ENT
Oral-motor findings should be interpreted alongside nasal obstruction, adenoid or tonsil burden, laryngeal function, hearing, and sleep.
ENT × IMMUNE
Separate common childhood infection, structural obstruction, allergy, mucosal barrier, culture-defined infection, and immunology interpretation of antibody response.
Open immune, skin & mucosa →CROSS-SYSTEM BIOLOGY
The current record contains one direct respiratory-chain assay, one caregiver-reported Complex I history, and additional carnitine, pyruvate, acylcarnitine, fasting, hydration, illness, and recovery observations. Their evidence levels and specimens are not equivalent, so the full analysis remains in Biology rather than being duplicated inside the GI phenotype.
Open Mitochondria & Cellular EnergyFEMALE × MALE SOURCE COVERAGE
Mapped plus unreported closes to the female or male roster total in every row. Formal-record anchors sit inside mapped and are never added as another person state. These are ascertainment counts, not symptom frequencies.
Scientific reading: the source map supports sex-stratified hypotheses and record-recovery priorities. It does not currently support a male–female prevalence or severity estimate.
CLINICAL MEASUREMENT
Speech-language and oromotor assessment, chewing examination, swallow evaluation when indicated, diet texture, dental structure, and oral tissue examination.
Motility and retention history, pain, reflux or vomiting, clinically indicated GI testing, hydration and growth, with state and recovery tracked over time.
ENT examination, tympanometry, audiology, operative history, and polysomnography or imaging only when the clinical question supports it.
Diet and intake, 25-hydroxy vitamin D, calcium, phosphate and PTH when indicated, weight-bearing, fracture history, puberty, and DXA with age/sex/reference details.